- US12377252utility2025Implantation Devices, System, and Methods0 cites
- US12371665utility2025Differentiation of Pancreatic Endocrine Cells0 cites
- US12350262utility2025Methods of Treatment for Cystic Fibrosis0 cites
- US12331057utility2025Modulators of Alpha-1 Antitrypsin0 cites
- US12331334utility2025Modified Urokinase-type Plasminogen Activator Polypeptides and Methods of Use0 cites
- USRE050453reissue2025Indole Derivatives as CFTR Modulators0 cites
- US12324802utility2025Modulators of Cystic Fibrosis Transmembrane Conductance Regulator0 cites
- US12319693utility2025Crystalline Forms of CFTR Modulators0 cites
- US12304900utility2025Islet Cell Manufacturing Compositions and Methods of Use0 cites
- US12281057utility2025Carboxamides as Modulators of Sodium Channels0 cites
- US12281102utility2025Inhibitors of APOL1 and Methods of Using Same0 cites
- US12269804utility2025Quinoxalinone Compounds, Compositions, Methods, and Kits for Increasing Genome Editing Efficiency0 cites
- US12269831utility2025Modulators of Cystic Fibrosis Transmembrane Conductance Regulator0 cites
- US12264337utility2025Differentiation of Pancreatic Endocrine Cells0 cites
- US12258333utility2025N-(hydroxyalkyl (hetero)aryl) Tetrahydrofuran Carboxamides as Modulators of Sodium Channels0 cites
- US12251387utility2025Substituted Quinoxalines and Benzo[c][1,2,5]oxadiazoles as DNA-PK Inhibitors0 cites
- US12247021utility2025Substituted Tetrahydrofurans as Modulators of Sodium Channels0 cites
- US12227765utility2025Differentiation of Pancreatic Endocrine Cells0 cites
- US12214083utility2025Pharmaceutical Composition and Administrations Thereof0 cites
- US12215355utility2025Stem Cell Derived Islet Differentiation0 cites